Use Biopath Holdings Inc performance together with your portfolio for risky short term speculation or day-trading and to determine OTC Equity optimization strategy that fits your criteria.
If you would invest 27.00 in Biopath Holdings Inc on April 25, 2012 and sell it today you would earn a total of 7.00 from holding Biopath Holdings Inc or generate 25.93% return on investment over 30 days. Biopath Holdings Inc is generating 1.36% of daily returns and assumes 8.4% volatility on return distribution over the 30 days horizon. Simply put, majority of traded equity instruments are less risky than Biopath Holdings Inc on the bases of their historical return distribution and most equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
Risk [Daily Volatility] (%)
Assuming 30 trading days horizon, Biopath Holdings Inc is expected to generate 11.05 times more return on investment than the market. However, the company is 11.05 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The NYSE is currently generating roughly -0.39 per unit of risk.
Biopath Operating Margin
Based on recorded statements Biopath Holdings Inc has Operating Margin of 0.0%. This is 100.0% lower than that of Healthcare sector, and 100.0% lower than that of Drug Delivery industry, The Operating Margin for all stocks is 100.0% lower than the firm.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
94% of all equities and portfolios perform better than Biopath Holdings Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Biopath Holdings Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.
1 Month Effecincy (a.k Sharpe Ratio) ...
0.16
BestPortfolio
BestEquity
BPTH
Good Returns
Average Returns
Small Returns
Cash
SmallRisk
AverageRisk
HighRisk
HugeRisk
Negative Returns
Estimated Market Risk
8.4
actual daily
4 %
of total potential
Expected Return
1.36
actual daily
95 %
of total potential
Risk-Adjusted Return
0.16
actual daily
6 %
of total potential
Based on monthly moving average Biopath is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biopath by adding it to a well-diversified portfolio.
Follow Biopath Performance with your standard RSS feed, custom widget, or your favorite social app
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
Management
Discussion
